Investor Presentation on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
Q1FY27 results (unaudited):
Consolidated:
Revenue 6.951bn +13% y-y (6.132bn)
EBITDA 1.223bn +13% y-y (1.078bn)
EBITDA margin 17.6% (17.6%) +/-0 bps y-y
PAT 0.138bn +190% y-y (0.048bn)
Commentary: Adjusted EBITDA excludes North Bangalore loss of INR 70 Mn and EPCG-related provision of INR 45.9 Mn in Q1 FY27 and ESOP of INR 14.5 Mn and M&A-related costs of INR 25.6 Mn in Q1 FY26. North Bangalore facility commenced operations in May 2026 and contributed revenue of INR 67 million in Q1 FY27.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 HCG — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add HCG to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Healthcare Global Enterprises Limited
Important.
The summary above is generated automatically from Healthcare Global Enterprises Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.